Explanatory Indicators Sample Clauses

Explanatory Indicators. Without limiting the definition of “Explanatory Indicator” set out in s. 1.1, Explanatory Indicators: • are complementary indicators to the Accountability Indicators and will be documented in the technical specifications of the most appropriate Accountability Indicator(s); • support planning, negotiation or problem-solving at the provincial, LHIN level or agency level; • support transparency and enable planning discussions; • support of improving and sustaining health system quality, effectiveness and efficiency; • are indicators where data may already be provided through existing reporting systems; and • will not trigger consequences under the SAA (unless otherwise specified in a Performance Improvement Plan or new funding obligations). Turnover Rate is an example of an Explanatory Indicator. Schedule E1 CORE INDICATORS- All Sectors CORE INDICATORS- ALL SECTORS‌ Healthcare Service Provider: The Aphasia Intstitute Accountability Indicators 2011-2012 2012-2013 2013-2014 Target Performance Standard Target Performance Standard Target Performance Standard % Total Margin 0% >=0% 0% >=0% XXX XXX Fund Type 2- Balanced Budget 0 0 0 0 XXX XXX Proportion of Budget Spent on Administration 57% < 68% 57% < 69% XXX XXX Variance Forecast to Actual Expenditures 0.0% < 5% 0.0% < 5% XXX XXX Variance Forecast to Actual Units of Service 0.0% < 5% 0.0% < 5% XXX XXX Explanatory Indicators Cost per Unit Service (by Functional Centre) Cost per Individual Served (by program/service) Turnover Rate Repeat Unplanned Emergency Visits within 30 days - Mental Health Conditions Repeat Unplanned Emergency Visits within 30 days - Substance Abuse Conditions Percentage of Alternate Level of Care (ALC) days Schedule E2a CORE INDICATORS- All Sectors CSS IH COM - Caregiver Support 72 5 82 50 S 448*, 449*, 450*, 451*, 455* Full-time equivalents (FTE) S 310*,350*,380*,390* (Earned Hours) divided by 1950= FTE *1.5 N/A *1.5 N/A *TBD N/A CSS IH COM - Caregiver Support 72 5 82 50 S 448*, 449*, 450*, 451*, 455* Visits Face-to-face, Telephone In-House, Contracted Out S 450*, 451*, 448*, 449* 2800 2520 - 3080 2800 2520 - 3080 XXX XXX CSS IH COM - Caregiver Support 72 5 82 50 S 448*, 449*, 450*, 451*, 455* Individuals Served by Functional Centre or as appropriate Individuals Served by Organization S. 455*, 855* 219 175 - 263 219 175 - 263 XXX XXX CSS IH COM - Caregiver Support 72 5 82 50 S 448*, 449*, 450*, 451*, 455* Total Cost for Functional Centre *$93,120 N/A *$93,120 N/A *TBD N/A CSS ABI - Day Servi...
AutoNDA by SimpleDocs
Explanatory Indicators. Without limiting the definition of “Explanatory Indicator” set out in s. 1.1, Explanatory Indicators: • are complementary indicators to the Accountability Indicators and will be documented in the technical specifications of the most appropriate Accountability Indicator(s); • support planning, negotiation or problem-solving at the provincial, LHIN level or agency level; • support transparency and enable planning discussions; • support of improving and sustaining health system quality, effectiveness and efficiency; • are indicators where data may already be provided through existing reporting systems; and • will not trigger consequences under the SAA (unless otherwise specified in a Performance Improvement Plan or new funding obligations). Turnover Rate is an example of an Explanatory Indicator. Schedule E1 CORE INDICATORS- All Sectors

Related to Explanatory Indicators

  • Regulatory Inspections Manufacturer will permit Rhythm or its agents to be present and participate in any visit or inspection by any Authority of the Facility (to the extent it relates in any way to any Product) or the Manufacturing Process. Manufacturer will give as much advance notice as reasonably possible to Rhythm of any such visit or inspection. Manufacturer will provide Rhythm with a copy of any report or other written communication * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. received from such Authority in connection with such visit or inspection, and any written communication received from any Authority relating to any Product, the Facility (if it relates to or affects the Development and/or Manufacture of Product) or the Manufacturing Process, within two (2) business days after receipt, and will consult with, and require approval from, Rhythm before responding to each such communication. Manufacturer will provide Rhythm with a copy of its final responses within five (5) business days after submission.

  • Commercialization Plan (a) Not later than three [***] after submission of Regulatory Filings for each Product in each country of the Territory, Licensee will provide to the JCC for review its initial Commercialization Plan for each Product for each country in the Territory. Such initial Commercialization Plan will describe Licensee’s plans for activities to be conducted for such Product for such country. Each Commercialization Plan shall include the details of obligations to be performed by Licensee to achieve the specific activities that are applicable to the stage of [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Commercialization (e.g., pre-launch, launch planning, launch, or post-launch) of the applicable Product during the time period covered by such Commercialization Plan and subsequent time periods. (b) Prior to the First Commercial Sale for such Product in such country, Licensee will provide to the JCC for review an updated Commercialization Plan for such Product for such country. Such updated Commercialization Plan will include, but not be limited to, Licensee’s updated plans for activities to be conducted for such Product for such country prior to launch as well as activities to be conducted in connection with such launch. (c) Promptly after each anniversary of the First Commercial Sale of such Product during the Term, Licensee will provide to the JCC for review updated Commercialization Plans for such Product for such country. Such further updated Commercialization Plan will include, but not be limited to, Licensee’s plans for Commercialization activities for such Product and such country for the twelve (12) month period following the date of delivery of such Commercialization Plan. No Commercialization Plan may be implemented by Licensee if [***]. Each Commercialization Plan shall be consistent with and shall not contradict the terms of this Agreement [***], and in the event of any inconsistency between the Commercialization Plan and this Agreement, the terms of this Agreement shall prevail. Notwithstanding the foregoing, if a [***], Licensee shall [***] and shall promptly [***].

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Regulatory Issues 3.3.1 The Licensee shall be solely responsible for determining which jurisdictions they choose to market to and receive xxxxxx from. 3.3.2 The Licensee shall be responsible for determining the legality of accepting xxxxxx in whichever jurisdictions they choose to market to and receive xxxxxx from. 3.3.3 The Licensee shall indemnify UNITED for any reasonable legal costs, and fines that arise as a result of the Licensee choosing to accept xxxxxx from any jurisdiction that determines or has determined that Internet wagering is illegal.

  • Marketing Plan The MCOP shall submit an annual marketing plan to ODM including all planned activities for promoting membership in or increasing awareness of the MCOP. The marketing plan submission shall include an attestation by the MCOP that the plan is accurate and is not intended to mislead, confuse, or defraud the eligible individuals or ODM.

  • Product Changes Vocera shall have the right, in its absolute discretion, without liability to End User, to update to provide new functionality or otherwise change the design of any Product or to discontinue the manufacture or sale of any Product. Vocera shall notify End User at least 90 days prior to the delivery of any Product which incorporates a change that adversely affects form, fit or function (“Material Change”). Vocera shall also notify End User at least 90 days prior to the discontinuance of manufacture of any Product. Notification will be made as soon as reasonably practical for changes associated with regulatory or health and safety issues.

  • Third Party Websites The Service may contain or reference links to websites operated by third parties ("Third Party Websites"). These links are provided as a convenience only. Such Third Party Websites are not under our control. We are not responsible for the content of any Third Party Website or any link contained in a Third Party Website. We do not review, approve, monitor, endorse, warrant, or make any representations with respect to Third Party Websites, and the inclusion of any link in the Service, Debit Rewards Offers or any other services provided in connection with them is not and does not imply an affiliation, sponsorship, endorsement, approval, investigation, verification or monitoring by us of any information contained in any Third Party Website. In no event will we be responsible for the information contained in such Third Party Website or for your use of or inability to use such website. Access to any Third Party Website is at your own risk, and you acknowledge and understand that linked Third Party Websites may contain terms and privacy policies that are different from ours. We are not responsible for such provisions, and expressly disclaim any liability for them.

  • Regulatory Information (a) All the notaries at De Pinna LLP are regulated through the Faculty Office of the Archbishop of Canterbury. Its address is The Faculty Office, 0 Xxx Xxxxxxxxx, Xxxxxxxxxxx, Xxxxxx XX0X 0XX, its telephone: 000 0000 0000, and it can be reached by email at xxxxxxx.xxxxxx@0xxxxxxxxxxxx.xxx. It also has a website at xxx.xxxxxxxxxxxxx.xxx.xx. (b) We are required to comply with the rules of professional conduct and other regulatory arrangements of the Master of the Faculties, the sole regulator of notarial activities under the Legal Services Act 2007. Information about those rules and regulations may be found at xxxx://xxx.xxxxxxxxxxxxx.xxx.xx/notary/i-am-a-notary/notaries-rules-regulations/. (c) We comply with the Code of Practice published by the Master of the Faculties: xxxx://xxx.xxxxxxxxxxxxx.xxx.xx/notary/code-of-practice.

  • Marketing Plans Contractor and the Exchange recognize that Enrollees and other health care consumers benefit from efforts relating to outreach activities designed to increase heath awareness and encourage enrollment. The parties shall share marketing plans on an annual basis and with respect to periodic updates of material changes. The marketing plans of each of the Exchange and Contractor shall include proposed marketing approaches and channels and shall provide samples of any planned marketing materials and related collateral as well as planned, and when completed, expenses for the marketing budget. The Contractor shall include this information for both the Exchange and the outside individual market. The Exchange shall treat all marketing information provided under this Section as confidential information and the obligation of the Exchange to maintain confidentiality of this information shall survive termination or expiration of this Agreement.

  • THIRD PARTY WEBSITES AND CONTENT The Website contains (or you may be sent through the Website or the Company Services) links to other websites ("Third Party Websites") as well as articles, photographs, text, graphics, pictures, designs, music, sound, video, information, applications, software and other content or items belonging to or originating from third parties (the "Third Party Content"). Such Third Party Websites and Third Party Content are not investigated, monitored or checked for accuracy, appropriateness, or completeness by us, and we are not responsible for any Third Party Websites accessed through the Website or any Third Party Content posted on, available through or installed from the Website, including the content, accuracy, offensiveness, opinions, reliability, privacy practices or other policies of or contained in the Third Party Websites or the Third Party Content. Inclusion of, linking to or permitting the use or installation of any Third Party Website or any Third Party Content does not imply approval or endorsement thereof by us. If you decide to leave the Website and access the Third Party Websites or to use or install any Third Party Content, you do so at your own risk and you should be aware that our terms and policies no longer govern. You should review the applicable terms and policies, including privacy and data gathering practices, of any website to which you navigate from the Website or relating to any applications you use or install from the Website. Any purchases you make through Third Party Websites will be through other websites and from other companies, and Company takes no responsibility whatsoever in relation to such purchases which are exclusively between you and the applicable third party. Company reserves the right but does not have the obligation to:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!